Preliminary approval for the making of Covishield given to SII: Final decision of DCGI pending
New Delhi, January 1, 2021 The SII or the Serum Institute of India, that is making Covishield, the vaccine that has been developed by the Oxford University and AstraZeneca the reputed pharma company has been given the nod. The final decision rests with the regulator, the DCGI (Drugs Controller General of India) is now awaited. […]